GSK2636771 |
|
| Synonyms: 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid;GSK 2636771 | |
| Cat. No.: G98100 | CAS No.: 1391712-60-9 |
| MDL.: | Formula: C22H22F3N3O3 |
| F.W.433.42 | Purity: 99% |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 5mg | $275.00 | Enter qty and click checkbox |
 
|
$275.00 |
| Catalog Number： | G98100 | CAS No.: | 1391712-60-9 | |
| MDL: | Formula: | C22H22F3N3O3 | ||
| F.W.: | 433.42 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | Category: | Reference Standard | ||
| Application: | GSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor | |||